Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

Stanley R. Kay, Abraham Fiszbein, Lewis A. Opler · Schizophrenia Bulletin · 1987 · 21K citations · Full text

Psychopathology, Psychiatry, Psychotic Disorder +11

Prediction of psychosis. A step towards indicated prevention of schizophrenia.

Alison R. Yung, Lisa Phillips, Patrick D. McGorry et al. · PubMed · 1998 · 700 citations

Prediction of psychosis

Alison R. Yung, Lisa Phillips, Patrick D. McGorry et al. · The British Journal of Psychiatry · 1998 · 630 citations

Epidemiology, Psychopathology, Psychiatry +13

Alterations in Brain High-Energy Phosphate and Membrane Phospholipid Metabolism in First-Episode, Drug-Naive Schizophrenics

Jay W. Pettegrew · Archives of General Psychiatry · 1991 · 479 citations

The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells.

Raffaele De Caterina, Myron I. Cybulsky, Steven K. Clinton et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1994 · 466 citations · Full text